CCCN

Las Vegas, Nevada 89169

0 studies enrolling now · 3 studies all time

What they study most

Biliary Tract Cancer, CRC, Colorectal Cancer, KRAS/NRAS Mutation, Metastatic Colorectal Cancer

Studies at this site

• Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation — Running, not enrolling
• Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO) — Stopped early
• Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer — Completed